Works matching IS 00071188 AND DT 2004 AND VI 141 AND IP 8

Results: 11

Treating irritable bowel syndrome: overview, perspective and future therapies.

Published in:

2004

By:

Camilleri, Michael

Publication type:

journal article

Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1303, doi. 10.1038/sj.bjp.0705742

By:

Sanger, Gareth J.

Publication type:

Article

Modulation of visceral pain and inflammation by protease-activated receptors.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1264, doi. 10.1038/sj.bjp.0705750

By:

Vergnolle, Nathalie

Publication type:

Article

Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1249, doi. 10.1038/sj.bjp.0705751

By:

Lecci, Alessandro;
Capriati, Angela;
Maggi, Carlo Alberto

Publication type:

Article

CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Published in:

2004

By:

Taché, Y.;
Martinez, V.;
Wang, L.;
Million, M.;
Taché, Y

Publication type:

journal article

Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome.

Published in:

2004

By:

Galligan, James J.

Publication type:

journal article

Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1285, doi. 10.1038/sj.bjp.0705762

By:

Crowell, Michael D.

Publication type:

Article

Peripheral kappa-opioid agonists for visceral pain.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1331, doi. 10.1038/sj.bjp.0705763

By:

Pierre J.-M. Riviére

Publication type:

Article

Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1313, doi. 10.1038/sj.bjp.0705768

By:

Geppetti, Pierangelo;
Trevisani, Marcello

Publication type:

Article

Involvement of endogenous CCK and CCK1 receptors in colonic motor function.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1275, doi. 10.1038/sj.bjp.0705769

By:

Varga, Gábor;
Bálint, András;
Burghardt, Beáta;
D'Amato, Massimo

Publication type:

Article

Involvement of cannabinoid receptors in gut motility and visceral perception.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 8, p. 1335, doi. 10.1038/sj.bjp.0705783

By:

Hornby, Pamela J.;
Prouty, Stephen M.

Publication type:

Article

Works matching IS 00071188 AND DT 2004 AND VI 141 AND IP 8

Treating irritable bowel syndrome: overview, perspective and future therapies.

Neurokinin NK<sub>1</sub> and NK<sub>3</sub> receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Modulation of visceral pain and inflammation by protease-activated receptors.

Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome.

Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Peripheral kappa-opioid agonists for visceral pain.

Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.

Involvement of endogenous CCK and CCK<sub>1</sub> receptors in colonic motor function.

Involvement of cannabinoid receptors in gut motility and visceral perception.